Communicating Clinical Trial Results to Study Volunteers:
The Critical Role of Post-trial Communication in Engaging Patients as Partners in Clinical Research (Best Practices)

Nearly 40% of the global public feels that clinical research volunteers are ‘experimental test subjects, not people.’ While there is widespread recognition that study volunteers contribute to the advancement of public health, the research community still has plenty of opportunity to treat them as true partners in the discovery of new medical treatments. Research demonstrates that substantial progress can be made in addressing this situation with relatively minor adjustments to end-of-study practices: a commitment to sharing the findings of the trial with all volunteers who gave the gift of their participation.

This webinar will discuss the following:

• The value and feasibility of communicating clinical trial results in everyday language, from patient, sponsor and regulatory perspectives, drawing on global research conducted by the non-profit CISCRP.
• An overview of CISCRP’s program for communicating trial results to study volunteers: lessons learned and key findings from qualitative and quantitative program evaluations in our work with two dozen major and mid-size pharmaceutical and biotechnology companies since 2009.
• Recommendations and best practices to help sponsors educate and engage study volunteers in a meaningful way post-trial, while meeting growing regulatory expectations, ensuring strict non-promotionality, and minimizing burden on sponsor and site staff.